A detailed history of Pacer Advisors, Inc. transactions in Xencor Inc stock. As of the latest transaction made, Pacer Advisors, Inc. holds 543 shares of XNCR stock, worth $12,315. This represents 0.0% of its overall portfolio holdings.

Number of Shares
543
Previous 1,064 48.97%
Holding current value
$12,315
Previous $23,000 56.52%
% of portfolio
0.0%
Previous 0.0%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$18.21 - $24.5 $9,487 - $12,764
-521 Reduced 48.97%
543 $10,000
Q1 2024

May 10, 2024

BUY
$18.65 - $26.52 $19,843 - $28,217
1,064 New
1,064 $23,000
Q2 2021

Jul 21, 2021

SELL
$34.33 - $44.68 $47,718 - $62,105
-1,390 Closed
0 $0
Q1 2021

Apr 05, 2021

SELL
$40.81 - $53.88 $11,916 - $15,732
-292 Reduced 17.36%
1,390 $60,000
Q4 2020

Jan 20, 2021

SELL
$36.63 - $47.63 $16,776 - $21,814
-458 Reduced 21.4%
1,682 $73,000
Q3 2020

Oct 19, 2020

BUY
$30.09 - $43.02 $64,392 - $92,062
2,140 New
2,140 $83,000
Q4 2018

Feb 13, 2019

SELL
$32.39 - $42.05 $64,909 - $84,268
-2,004 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$35.69 - $47.65 $71,522 - $95,490
2,004 New
2,004 $78,000
Q1 2018

May 14, 2018

SELL
$21.18 - $33.78 $12,178 - $19,423
-575 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$19.29 - $24.83 $11,091 - $14,277
575
575 $13,000

Others Institutions Holding XNCR

About Xencor Inc


  • Ticker XNCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,698,100
  • Market Cap $1.35B
  • Description
  • Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...
More about XNCR
Track This Portfolio

Track Pacer Advisors, Inc. Portfolio

Follow Pacer Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pacer Advisors, Inc. with notifications on news.